DURHAM, N.C.--(BUSINESS WIRE)--Tryton Medical, Inc., the leading developer of stents designed to treat coronary bifurcation lesions, today announced the company will present results from the Tryton Confirmatory Study, a pivotal single-arm clinical trial evaluating use of the Tryton Side Branch Stent in patients with coronary bifurcation lesions involving side branches that are 2.25mm in diameter or greater. Results will be presented at Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation (CRF) to be held October 11-15, 2015 in San Francisco, Calif.
Help employers find you! Check out all the jobs and post your resume.
